The Biosimilars Market is valued at USD 34.61 Billion in 2024 and is expected to reach USD 205.65 Billion by 2035 at a CAGR ...

The Global pharmaceutical excipients Market is valued at USD 8.82 Billion in 2024 and is projected to reach a value of USD 16 ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

The next target appears to be the Pharmaceuticals industry - during a speech made ... companies to manufacture more and more of their product within the U.S., and is believed to be using tariffs ...

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Eton Pharmaceuticals, Inc., a specialty ...

Healthcare CDMO Market Maintaining product quality and consistency across production scales is crucial and often resource-intensive. US ...

We feel now is a pretty good time to analyse Avadel Pharmaceuticals plc's ( NASDAQ:AVDL ) business as it appears ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

Merck signs deal with Austria's Cyprumed to develop oral peptide therapies, potentially paying up to $493 million for access ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...